Claritas Genomics provides clinical genetic diagnostic testing using next-generation sequencing and a network of pediatric disease specialists to support clinicians. The company combines clinical expertise of pediatric specialists with sequencing technology to offer a range of diagnostic services. It plans to expand commercial operations and launch new sequencing-based tests for diagnosis of pediatric genetic disorders. Claritas also intends to continue building its network of clinical pediatric disease experts. The company is led by CEO Patrice Milos, Ph.D.

Total raised

$15M

Funding rounds

1

Latest round

Series B

Latest activity

Jan 2015